MeMed founders Eran Eden

Israeli Company MeMed Seeks to Provide Fast Bacterial POC Diagnostics

ImmunoXpert has the potential to significantly reduce overprescribing antibiotics by quickly differentiating bacterial and viral infections

Precision Med Team Sets Sights on Rare Disease Therapies

The UnDx Consortium will explore results of novel tests analyzing samples from six patients struggling with undiagnosed diseases.
The Icahn School of Medicine at Mt. Sinai is generating research that is updating our view of how mitochondrial DNA (mtDNA) is passed from generation to generation. In the traditional view

The Next Next Thing in Sequencing

Though it may seem to be navigating by perceptibly unfixed stars, next-generation sequencing (NGS) is journeying ever more adventurously into the obscure, the rare,...

Dozens of Genetic Links to Sleep Patterns Found

The genome-wide association study found 47 links between our genetic code and the quality, quantity, and timing of how we sleep, including ten linked with sleep duration and 26 with sleep quality.
Researchers based at Dana-Farber/Boston Children's Cancer and Blood Disorders Center test thousands of tumor genes in mice via CRISPR

Cancer Immunotherapy Checkpoint Escapes Identified Through CRISPR/Cas9

Researchers test thousands of tumor genes in mice via CRISPR, seeking targets that could enhance PD-1 checkpoint inhibitor effectiveness
Source: © fotoliaxrender -

Novel Diagnostic Genomic Analysis Technique Developed

Scientists from McGill University and the Génome Québec Innovation Centre say they have achieved a technical advance that could result in speedier diagnosis of...
A conceptual rendition of the CRISPR tape recording system. [Source: Wang lab/Columbia University Medical Center]

Columbia Researchers Use CRISPR as Mini Tape Recorder of In Vivo Biological Changes

CRISPR/Cas bacteria may one day be swallowed by patients as a diagnostic tool or to record temporal biological changes within the body
Source: goa_novi/Getty Images

Researchers Link Effect of Cancer Drug With Alzheimer’s-Protecting Mutation

Researchers identify a genetic mutation that produces the same effect as Gleevec to protect the elderly from developing Alzheimer's disease.
Source: Martin Barraud/Getty Images

LabCorp Snaps Up Sequenom in $371M Deal

LabCorp seeks to broaden its neonatal testing offerings and market presence in Europe and Asia via the Sequenom acquisition.

AMP Position Statement Offers Laboratories ‘Best Practices’ for PGx Testing

The Association for Molecular Pathology (AMP) today published a position statement for pharmacogenomic testing that spells out “best practices” criteria for laboratories to follow. The...
Scroll Up